Aurora Life Sciences (ALS) is dedicated to empowering diagnostics, providing life changing discoveries and enabling healthier decisions. Established in 2010, with an expertise in biophotonics and microarray technologies, ALS set out to enhance wellness testing with a focus on developing an innovative multiplexed autoimmune testing platform. The ALS Autoimmune 30+ panel achieves this by providing an extensive set of autoimmune disease markers in one test. This innovative, cost effective and time sensitive diagnostic tool provides an expanded overview of an individual’s autoimmune status.